Our company
About us
Management
Board of Directors
History
Areas of research
Research and technology
Pipeline
Actinic keratosis
Basal cell carcinoma
Leukemia
Triple-negative breast cancer
Chronic kidney disease (CKD)
Patents
Clinical trials
Investor relations
Why to invest
Press releases
Financial reports
Financial calendar
Event calender
The share
Shareholders
Warrants
Offer documents
Analysis
Presentations
Corporate governance
Articles of Association
Auditor
Previous IR Goldblue
IR Contact
Media
News
Press releases
Contact
Change language
English
Svenska
IR Contact
Tore Duvold
CEO
+45 61 90 50 66
[email protected]